Non-interventional Study Describing Patients' Perception on Anticoagulant Treatment and Treatment Convenience When Treated With Pradaxa or Vitamin K Antagonist for Stroke Prophylaxis in Atrial Fibrillation
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008727/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The aim of this non-interventional study is to describe patient's perception of anticoagulant
treatment when using Pradaxa® to prevent stroke and systemic embolism while suffering from
atrial fibrillation (according to its approved indication in the approved dosages of 110 mg
or 150 mg twice daily) in comparison to standard care using Vitamin K Antagonist (VKA).
提供机构：
Vivli
创建时间：
2023-01-16
